281 related articles for article (PubMed ID: 36275683)
1. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
Front Immunol; 2022; 13():1033794. PubMed ID: 36275683
[TBL] [Abstract][Full Text] [Related]
2. Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.
Chompunud Na Ayudhya C; Amponnawarat A; Ali H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070125
[TBL] [Abstract][Full Text] [Related]
3. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.
Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Oskeritzian CA; Ali H
Cells; 2021 Jan; 10(1):. PubMed ID: 33467419
[TBL] [Abstract][Full Text] [Related]
4. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells
Thapaliya M; Amponnawarat A; Tesmer JJG; Ali H
Front Immunol; 2022; 13():1032497. PubMed ID: 36275707
[TBL] [Abstract][Full Text] [Related]
5. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
Thapaliya M; Ali H
Front Immunol; 2023; 14():1155777. PubMed ID: 37063868
[TBL] [Abstract][Full Text] [Related]
6. New insight into prurigo nodularis: Proadrenomedullin N-terminal 20 peptide mediates mouse mast cell activation via Mrgprb2.
Shao Y; Xiao Z; Jin Y; Zhu Y; Shen Y; Jin T; Tang H; Wang D
Skin Res Technol; 2024 Feb; 30(2):e13588. PubMed ID: 38284237
[TBL] [Abstract][Full Text] [Related]
7. Identification of Gain and Loss of Function Missense Variants in MRGPRX2's Transmembrane and Intracellular Domains for Mast Cell Activation by Substance P.
Chompunud Na Ayudhya C; Roy S; Alkanfari I; Ganguly A; Ali H
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652731
[TBL] [Abstract][Full Text] [Related]
8. Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells
Amponnawarat A; Chompunud Na Ayudhya C; Ali H
Front Immunol; 2021; 12():689410. PubMed ID: 34248979
[No Abstract] [Full Text] [Related]
9. Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones.
Elst J; Maurer M; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; van der Poorten MM; De Puysseleyr LP; Hagendorens MM; Van Tendeloo VF; Lion E; Campillo-Davo D; Ebo DG
Front Immunol; 2021; 12():668962. PubMed ID: 34385999
[TBL] [Abstract][Full Text] [Related]
10. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2.
Hermans MAW; van Stigt AC; van de Meerendonk S; Schrijver B; van Daele PLA; van Hagen PM; van Splunter M; Dik WA
Front Immunol; 2021; 12():625284. PubMed ID: 33790895
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells.
Chaki S; Alkanfari I; Roy S; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
Front Immunol; 2021; 12():803335. PubMed ID: 35126366
[TBL] [Abstract][Full Text] [Related]
12. Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human β-Defensin-3, and Icatibant.
Alkanfari I; Gupta K; Jahan T; Ali H
J Immunol; 2018 Jul; 201(2):343-349. PubMed ID: 29794017
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B
Roy S; Ganguly A; Haque M; Ali H
J Immunol; 2019 Feb; 202(4):1229-1238. PubMed ID: 30651343
[TBL] [Abstract][Full Text] [Related]
14. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.
Chen E; Chuang LS; Giri M; Villaverde N; Hsu NY; Sabic K; Joshowitz S; Gettler K; Nayar S; Chai Z; Alter IL; Chasteau CC; Korie UM; Dzedzik S; Thin TH; Jain A; Moscati A; Bongers G; Duerr RH; Silverberg MS; Brant SR; Rioux JD; Peter I; Schumm LP; Haritunians T; McGovern DP; Itan Y; Cho JH
Gastroenterology; 2021 Apr; 160(5):1709-1724. PubMed ID: 33421512
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.
Adhikari N; Shim WS
Arch Pharm Res; 2022 Sep; 45(9):644-657. PubMed ID: 36183260
[TBL] [Abstract][Full Text] [Related]
16. MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcεRI-mediated events.
Baldo BA
Br J Clin Pharmacol; 2023 Nov; 89(11):3232-3246. PubMed ID: 37430437
[TBL] [Abstract][Full Text] [Related]
17. DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis.
Kunimura K; Akiyoshi S; Uruno T; Matsubara K; Sakata D; Morino K; Hirotani K; Fukui Y
J Allergy Clin Immunol; 2023 Jun; 151(6):1585-1594.e9. PubMed ID: 36804596
[TBL] [Abstract][Full Text] [Related]
18. All-trans-retinoic acid activated mast cells via Mas-related G-protein-coupled receptor-X2 in retinoid dermatitis.
Zheng Y; Che D; Peng B; Hao Y; Zhang X; He L; Geng S
Contact Dermatitis; 2019 Sep; 81(3):184-193. PubMed ID: 31006867
[TBL] [Abstract][Full Text] [Related]
19. Activation of ryanodine-sensitive calcium store drives pseudo-allergic dermatitis
Wang Z; Zhao X; Zhou H; Che D; Du X; Ye D; Zeng W; Geng S
Front Immunol; 2023; 14():1207249. PubMed ID: 37404822
[TBL] [Abstract][Full Text] [Related]
20. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca
Ding Y; Che D; Li C; Cao J; Wang J; Ma P; Zhao T; An H; Zhang T
Int Immunopharmacol; 2019 Jan; 66():185-197. PubMed ID: 30471617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
